Company intelligence / Profile preview

LINISE

Ownership: Private
Development stage: Other

Overview

Linise is a South Korean medical aesthetics company specializing in the development and manufacturing of advanced dermal fillers and skin rejuvenation products. The company's flagship product line includes hyaluronic acid-based fillers designed for various aesthetic applications, utilizing proprietary Multi-staged Cross-linking Technology (MCT) to ensure safety, high viscoelasticity, and longevity. In addition to fillers, Linise offers PDO (polydioxanone) lifting threads and other professional skincare solutions for the global aesthetic market. The company focuses on providing high-quality, CE-certified products to practitioners in the dermatology and plastic surgery fields, with a strong presence in international markets including Europe and Asia.

Therapeutic areas: Dermatology
Modalities: Medical deviceHyaluronic acid
Industry: Implantable Medical Devices

Partnerships

Koru Pharma

Beyond the preview

Go deeper on LINISE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LINISE.